326 related articles for article (PubMed ID: 11145184)
21. Glioblastoma treatment: bypassing the toxicity of platinum compounds by using liposomal formulation and increasing treatment efficiency with concomitant radiotherapy.
Charest G; Sanche L; Fortin D; Mathieu D; Paquette B
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):244-9. PubMed ID: 22284691
[TBL] [Abstract][Full Text] [Related]
22. Delivery of platinum (II) drugs with bulky ligands in trans-geometry for overcoming cisplatin drug resistance.
Yang X; Yu Y; Huang X; Chen Q; Wu H; Wang R; Qi R; Miao Y; Qiu Y
Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():96-104. PubMed ID: 30606608
[TBL] [Abstract][Full Text] [Related]
23. Increased delivery of a new cisplatin analogue (254-S) in a rat brain tumor by an intracarotid infusion of bradykinin.
Koga H; Inamura T; Ikezaki K; Nomura T; Samoto K; Fukui M
Neurol Res; 1996 Jun; 18(3):244-7. PubMed ID: 8837061
[TBL] [Abstract][Full Text] [Related]
24. Liposomes as carriers of cisplatin into the central nervous system--experiments with 9L gliomas in rats.
Shibata S; Ochi A; Mori K
Neurol Med Chir (Tokyo); 1990 Apr; 30(4):242-5. PubMed ID: 1696693
[TBL] [Abstract][Full Text] [Related]
25. [Therapeutic efficacy of intracarotid infusion of 20% mannitol with ACNU in Fischer rats with intracerebrally implanted 9L gliosarcoma].
Miyagami M; Tazoe M; Kasahara E; Tsubokawa T
Gan To Kagaku Ryoho; 1989 May; 16(5):2059-65. PubMed ID: 2499268
[TBL] [Abstract][Full Text] [Related]
26. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
[TBL] [Abstract][Full Text] [Related]
27. [Comparative study of the action of antineoplastic platinum compounds with varying nephrotoxic effects].
Bakhteeva VT; Fok EM; Lavrova EA
Vopr Med Khim; 1996; 42(4):301-6. PubMed ID: 9254514
[TBL] [Abstract][Full Text] [Related]
28. Kinetics of tissue disposition of cis-ammine/cyclohexylamine-dichloroplatinum(II) and cisplatin in mice bearing FSaIIC tumors.
Yoshida M; Khokhar AR; Zhang YP; Thai G; Siddik ZH
Cancer Chemother Pharmacol; 1994; 35(1):38-44. PubMed ID: 7987975
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of aqua (1,1-bis(aminomethyl)cyclohexane) sulfatoplatinum (II) (spiroplatin) during a phase I trial.
van der Vijgh WJ; Elferink F; Vermorken JB; ten Bokkel Huinink WW; Klein I; Gall HE; Simonetti G; McVie JG; Pinedo HM
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):621-7. PubMed ID: 3383966
[TBL] [Abstract][Full Text] [Related]
30. Platinum concentrations in uterus and serum after internal iliac arterial infusion of platinum compounds in rabbits.
Kigawa J; Minagawa Y; Itamochi H; Kanamori Y; Ishihara H; Terakawa N
Obstet Gynecol; 1995 Aug; 86(2):265-8. PubMed ID: 7617358
[TBL] [Abstract][Full Text] [Related]
31. [Pharmacodynamics of tongue tissue and plasma after intraarterial infusion of cis-diammine glycolato platinum (CDGP)].
Matsui T; Kano M
Nihon Jibiinkoka Gakkai Kaiho; 2004 Nov; 107(11):990-7. PubMed ID: 15624504
[TBL] [Abstract][Full Text] [Related]
32. Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor.
Nakagawa H; Fujita T; Kubo S; Tokiyoshi K; Yamada M; Kanayama T; Hagiwara Y; Nakanomyo H; Hiraoka M
Cancer Chemother Pharmacol; 1996; 37(4):317-26. PubMed ID: 8548876
[TBL] [Abstract][Full Text] [Related]
33. Reduced systemic drug exposure by combining intraarterial cis-diamminedichloroplatinum(II) with hemodialysis of regional venous drainage.
Oldfield EH; Clark WC; Dedrick RL; Egorin MJ; Austin HA; DeVroom HD; Joyce KM; Doppman JL
Cancer Res; 1987 Apr; 47(7):1962-7. PubMed ID: 3815385
[TBL] [Abstract][Full Text] [Related]
34. In vivo microdialysis to characterize drug transport in brain tumors: analysis of methotrexate uptake in rat glioma-2 (RG-2)-bearing rats.
Devineni D; Klein-Szanto A; Gallo JM
Cancer Chemother Pharmacol; 1996; 38(6):499-507. PubMed ID: 8823490
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model.
Dzodic R; Gomez-Abuin G; Rougier P; Bonnay M; Ardouin P; Gouyette A; Rixe O; Ducreux M; Munck JN
Anticancer Drugs; 2004 Jul; 15(6):647-50. PubMed ID: 15205611
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
[TBL] [Abstract][Full Text] [Related]
37. Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats.
Hanada K; Asano K; Nishimura T; Chimata T; Matsuo Y; Tsuchiya M; Ogata H
J Pharm Pharmacol; 2008 Mar; 60(3):317-22. PubMed ID: 18284811
[TBL] [Abstract][Full Text] [Related]
38. Atypical pharmacokinetics and excretion of new platinum analogues in rodents.
Webster LK; Ellis AG; Apicella C; Deacon GB
Cancer Chemother Pharmacol; 2002 Jan; 49(1):87-92. PubMed ID: 11855757
[TBL] [Abstract][Full Text] [Related]
39. [Distribution of cis-diamminedichloroplatinum in patients with metastatic brain tumors after intravenous or intracarotid administration].
Nakagawa H; Fujita T; Izumoto S; Kubo S; Nakajima Y; Turuzono K
Gan To Kagaku Ryoho; 1991 Jan; 18(1):103-9. PubMed ID: 1987891
[TBL] [Abstract][Full Text] [Related]
40. Clinical pharmacokinetics of carboplatin.
van der Vijgh WJ
Clin Pharmacokinet; 1991 Oct; 21(4):242-61. PubMed ID: 1760899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
